Search

Author/Creator Perry, Jason K.

1. Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII). Issue 3 (1st February 2018)

Authors:
Koltun, Dmitry O.; Parkhill, Eric Q.; Kalla, Rao; Perry, Thao D.; Elzein, Elfatih; Li, Xiaofen; Simonovich, Scott P.; Ziebenhaus, Christopher; Hansen, Timothy R.; Marchand, Bruno; Hung, WaiLok K.; Lagpacan, Leanna; Hung, Magdeleine; Aoyama, Ron G.; Murray, Bernard P.; Perry, Jason K.; Somoza, Joh...
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 28:Issue 3(2018)
Page Start:
541
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®. Issue 16 (15th August 2019)

Authors:
Link, John O.; Taylor, James G.; Trejo-Martin, Alejandra; Kato, Darryl; Katana, Ashley A.; Krygowski, Evan S.; Yang, Zheng-Yu; Zipfel, Sheila; Cottell, Jeromy J.; Bacon, Elizabeth M.; Tran, Chinh V.; Yang, Cheng Y.; Wang, Yujin; Wang, Kelly W.; Zhao, Guangyu; Cheng, Guofeng; Tian, Yang; Gong, Ruo...
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 29:Issue 16(2019)
Page Start:
2415
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search